Emerging research from the recent Society of Interventional Radiology (SIR) conference suggests the combination of transarterial radioembolization (TARE) and immunotherapy may offer improved three-year survival outcomes for patients with breast cancer and liver metastases.
For patients with no-option chronic limb-threatening ischemia (CLTI), transcatheter arterialization provided over a 25 percent higher amputation-free survival rate over standard medical management at one year, according to research presented at the Society of Interventional Radiology (SIR) Annual Scientific Meeting.
In a cohort of patients with invasive breast cancer and tumor sizes ranging between 0.3 to 9 cm, image-guided cryoablation was associated with a 10 percent recurrence rate at 16 months, according to research recently presented at the Society of Interventional Radiology (SIR) conference.
For men with prostate cancer, the use of MRI-guided transurethral ultrasound ablation (TULSA) led to a 92 percent decrease in median prostate volume at one year, according to new research recently presented at Society of Interventional Radiology (SIR) conference.
In a recent video interview, interventional radiologist Lindsay Machan, MD, discussed his longtime work with selective salpingography and fallopian tube recanalization to assist women with infertility issues, and key findings from a new study that he recently presented at the Society of Interventional Radiology (SIR) conference.
Selective salpingography may provide enhanced assessment of fallopian tubes and fallopian tube recanalization could be a viable alternative to facilitate natural conception, according to new research from the Department of Radiology at the University of British Columbia.
